Volastra Therapeutics, Inc.

CIK 1968822 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Volastra Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 23, 2025D0001968822-25-000002
May 30, 2024D0001968822-24-000001
Mar 13, 2023D0001968822-23-000001